News
New prescriptions of Esyma are suspended by MHRA
In December, the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) started a review of the treatment for abnormal bleeding in women with uterine fibroids after...
Clinical Trials
Aimmune’s peanut succeeds at phase||| trials
U.S. drug developer Aimmune Therapeutics said on Tuesday its peanut allergy drug met the main goal of an eagerly awaited late-stage study, sending its...
Production & Manufacturing
Arix secures partnership with Ipsen
The deal gives Ipsen access to Arix’ network of professional and scientific advisors, and the chance to invest in the firm’s new and existing...
News
Richard Wolf Announces the Opening of New Office in Singapore
Richard Wolf, answering strong global demand for its high-performance endoscopic technology services, today announced plans to expand in Southeast Asia by opening its 15th...
Press Releases
AbbVie and Voyager Therapeutics collaborates for Neurodegenerative Diseases
AbbVie , a global biopharmaceutical company, and Voyager Therapeutics, Inc. , a clinical-stage gene therapy company announced that they have entered into an exclusive...
Clinical Trials
AbbVie’s elagolix on a great roll in its PH3 trials
Clinical response was defined as menstrual blood loss volume of less than 80 mL during month six and a 50 percent or greater reduction...
News
Larotrectinib data published in The New England Journal of Medicine: Bayer
Bayer and Loxo Oncology, Inc., , a biopharmaceutical company from Stamford announced the publication in The New England Journal of Medicine (NEJM) of larotrectinib...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read